Clinical Trials

At Aggamin, we are dedicated to advancing medical treatments for vascular diseases, with a particular focus on preeclampsia. Our clinical trials are designed to evaluate the safety and effectiveness of new therapies that can make a significant impact on healthcare. We conduct rigorous studies to ensure that every treatment is thoroughly tested, and we collaborate with experts in the field to drive innovation.

Ongoing Clinical Trials

We are currently conducting clinical trials on treatments for preeclampsia, a condition that affects 5% of pregnancies and incurs a significant cost to the U.S. healthcare system. Our trials aim to provide safe, effective solutions for managing this condition and improving outcomes for both mothers and babies.

Participant Information

If you are interested in participating in one of our clinical trials, we encourage you to reach out to us for more details. Your participation is crucial to advancing the development of effective treatments for vascular diseases and preeclampsia. We are committed to ensuring a transparent and supportive environment.

Join Us in Revolutionizing Vascular Health

Become a part of our mission to develop groundbreaking therapies for critical vascular diseases. Together, we can make a difference in the lives of patients and healthcare systems globally.